Zylex Pharmaceuticals Inc Coeur D Alene, ID - 83815

Zylex Pharmaceuticals Inc is categorized under Wholesale Pharmaceutical Products in Coeur D Alene, ID and active since 2000.

Zylex Pharmaceuticals Inc was established in 2000, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact Trevor Yankoff at the company’s single location by writing to 315 West Dalton Avenue # 105, Coeur D Alene, Idaho ID 83815 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Zylex Pharmaceuticals Inc
Contact Person: Trevor Yankoff
Address: 315 West Dalton Avenue # 105, Coeur D Alene, Idaho 83815
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2000
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Zylex Pharmaceuticals Inc was started in 2000 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Trevor Yankoff for inquiries that concern Zylex Pharmaceuticals Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Zylex Pharmaceuticals Inc can be found at the coordinates 47.722834,-116.791884 as well as the street address 315 West Dalton Avenue # 105 in Coeur D Alene, Idaho 83815.

For its online presence, you may visit Zylex Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.